Prof. Pervin İşeri is a neurologist with a focused interest in movement disorders and neurodegenerative diseases. After completing medical studies at Atlas University Faculty of Medicine (2019–2021), she joined Acıbadem Health Group in 2025, where she contributes clinical expertise and patient care in neurology. She is actively involved in professional and advocacy organizations, including the Parkinson’s Association of Turkey, the Movement Disorders Society, the Neurodegenerative Diseases Association, and the Turkish Neurology Association. She serves with the Eskişehir branch of the Alzheimer’s Association of Turkey and sits on the advisory board of the Kocaeli Alzheimer’s Association. Additionally, she is a member of the Kocaeli Medical Chamber and a full member of the European Neurological Association. Dr. İşeri combines clinical practice with engagement in professional networks to advance care and awareness for patients with Parkinson’s, Alzheimer’s, and related neurological conditions.
Education
- 2019 – 2021 Faculty of Medicine Atlas University / Prof. Dr.
- 2011 Medical Specialization Board Clinical Neurophysiology
- 2002 Gazi University Faculty of Medicine Neurology
- 1993 Gazi University Faculty of Medicine
Experience
- 2025 Acibadem Health Group
- 2012 – 2019 Faculty of Medicine Kocaeli University / Prof. Dr.
- 2006 – 2012 Faculty of Medicine Kocaeli University / Assoc. Prof. Dr.
- 2005 Yale University Medical School Movement Disorders Department- Botulinum toxin treatment clinic-USA
- 2002 Faculty of Medicine Kocaeli University / Assoc.
- 2002 Faculty of Medicine Kocaeli University / Specialist Dr.
- 1998 – 2002 Faculty of Medicine Kocaeli University / Dr.Ar.Assist.
- 1993 – 1997 Isparta Center health center doctor / General practitioner (compulsory service)
Memberships
- Parkinson’s Association of Turkey
- Movement Disorders Society
- Neurodegenerative Diseases Association
- Turkish Neurology Association
- Member of Eskişehir Branch of Alzheimer’s Association of Turkey
- Kocaeli Alzheimer’s Association Advisory Board
- Kocaeli Medical Chamber
- Full member of the European Neurological Association
Publications
- Evaluation of cognitive deficits in patients infected with COVID-19.
Eur Rev Med Pharmacol Sci. 2022 Jan;26(2):678-685. doi: 10.26355/eurrev_202201_27894. PMID: 35113443 Arica-Polat BS, Gündoğdu AA, Cinar N, Uncu G, Ayaş ZO, İşeri P, Karadas O, Adapinar DO - Parkinson’s plus Syndromes, Copticobasal degeneration,
Review, Türkiye Klinikleri 2021 Pervin İşeri, Demet Gücüyener - Current Treatments for Alzheimer’s Disease
Review, Türkiye Klinikleri 2021 Pervin İşeri, Demet Gücüyener - Clinical correlation of MRI-tractogarphy findings in hemifacial spasm patients whp are injected botulinum neurotoxin.
Neurology India, Accepted, 2021 Hakan Çavuş, Pervin İşeri. - Covid-19 pandemic: Impact on Movement Disorders
Clinics of Turkey, Review 2021 Pervin Iseri. - Linking a compound-heterozygous Parkin mutant (Q311R and A371T) to Parkinson’s disease by using proteomic and molecular approaches.
Neurochem Int. 2015 Jun-Jul;85-86:1-13. Ozgul S, Kasap M, Akpinar G, Kanli A, Guzel N, Karaosmanoglu K, Baikal AT, Iseri P. - The effect of etanercept and methylprednisolone on functional recovery of the facial nerve after crush injury
Otol Neurotol. 2014 Aug;35(7):1277-83. Topdag M, Iseri M, Topdag DO, Kokturk S, Ozturk M, Iseri P. - The effect of pulse methylprednisolone plus theophylline treatment on clinical, pulmonary and inflammatory markers in relapses of multiple sclerosis
Balkan Med J. 2013 Mar;30(1):33-6. İşeri P, Başyiğit I, Ozerdem C, Başyiğit H, Efendi H, Yıldız F. - Treatment with enhanced external counterpulsation improves cogrıitive functions in chronic heart failure patients.
Türk Kardiyol Dern Ars. 2013 Jul;41(5):418-28. Kozdag G, Iseri P, Gokce G, Ertas G, Aygun F, Kutlu A, Hebert K, UralD. - Insulinoma in the differential diagnosis of seizure disorder.
The journal of Neuropsychiatry and clinical Neurosciences. 2006;18:247-248. Alemdar M, Iseri P, Komsuoglu S.
